IGC Pharma, Inc. (IGC)
(Delayed Data from AMEX)
$0.36 USD
0.00 (0.59%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $0.36 0.00 (1.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
IGC Pharma, Inc. [IGC]
Reports for Purchase
Showing records 1 - 15 ( 15 total )
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Enters into Joint Venture Agreement in Vertical Farming Technology
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Hires New Executive to Drive Initiative into Medicinal and Legal Marijuana Industry
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
We initiate coverage with a price target of $3.05 per share
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
ValuEngine Detailed Valuation Report for IGC
Provider: VALUENGINE, INC
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Initiating coverage with a Buy rating and a price target of $3.00.
Provider: REDCHIP
Analyst: KHANDEKAR A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
We are initiating coverage of IGC with a Buy rating and a price target of $3.00.
Provider: REDCHIP
|